NewsRoom Articles - CannabisNewsWire

WednesdayMar 22, 2023 4:20 am

420 with CNW — German Minister Confident That EU Will Sign Off on Germany’s Adult-Use Cannabis Proposals

Last year, German lawmakers unveiled a measure that would legalize recreational cannabis in the country. The bill would allow adults aged 21 years and older to purchase and possess up to 30 grams of cannabis for personal use as well as legalize the home cultivation of up to three mature cannabis plants per adult. Speaking at the time, Health Minister Karl Lauterbach said that the measure would help to protect the country’s young people as the current ban on recreational cannabis had proven to be ineffective. Although the measure still hadn’t received parliamentary approval at the time, the largest hurdle…

TuesdayMar 21, 2023 4:20 pm

420 with CNW — Synthetic Cannabinoids Drive Wedge Between Hemp, Marijuana Industries

Gold Spectrum, a hemp company based in Tennessee, is the most recent company to introduce a new line of edibles called Delta 8+ THC-O Cereal Bars, widening the rift between the hemp and marijuana industries. Since the 2018 farm bill's passage, delta-8 THC has gained widespread acceptance as a marijuana substitute in states where it is illegal, including Tennessee. THC-O is a relatively recent discovery; it is a synthetic cannabinoid produced through chemical synthesis that packs an intoxicating punch. It is also not covered by the farm bill such as naturally occurring cannabinoids derived from hemp. However, a growing number…

TuesdayMar 21, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Tracking Proprietary Path to Drug Delivery Innovation and Commercialization on Robust R&D Programs

Lexaria Bioscience is a global innovator in drug delivery platforms The company has been developing and commercializing patented DehydraTECH(TM), a technology that has been shown to increase the bioavailability of fat-soluble active molecules, improve the speed of onset and provide other benefits across multiple applications Lexaria has undertaken numerous R&D programs in an effort to build relationships with prospective corporate partners to out-license the technology or to form other profitable corporate relationships The company owes its achievements to its focus on R&D and the guidance provided by its highly experienced leadership, including CEO Chris Bunka, President John Docherty, as well…

TuesdayMar 21, 2023 9:00 am

India Globalization Capital Inc. (NYSE American: IGC) Reports Triple-Digit Revenue Growth, Phase 2 Study Highlights in Q3 2023 Report

Net revenue increased 133% to $332,000 in the three months ended Dec. 31, 2022, the company reports Corporate highlights included expanded trial sites, enrollment for phase 2 IGC-AD1 study Commencement of study marks milestone in IGC’s progress toward gaining FDA approval for proprietary treatment In a fragile economic environment, the third-quarter 2023 financial results reported by India Globalization Capital (NYSE American: IGC) are particularly remarkable. The company, which is pursuing effective treatment for Alzheimer’s patients suffering with agitation and other neuropsychiatric symptoms, released a report showing an increase in net revenue of 133% for the three-month period ending Dec. 31,…

TuesdayMar 21, 2023 4:20 am

420 with CNW — Adult-Use Cannabis Demand Exceeds Projections in Missouri

Since Missouri dispensaries started selling marijuana for recreational purposes more than a month ago, demand has outpaced expectations. In November 2022, a measure allowing for recreational cannabis sales was approved, opening the door for the establishment of dispensaries in the state. Marijuana sales reached $102.9 million in February, with recreational sales accounting for $71.7 million of the total. The first weekend of sales brought in $13 million. In addition to experiencing astronomical sales and customer numbers in its first month, Missouri has seen a nearly 50% increase in the wholesale price of marijuana flower. According to LeafLink — a wholesale…

MondayMar 20, 2023 4:20 pm

420 with CNW — Florida House Committee Approves Bill Allowing Telehealth Medical Cannabis Certification

A Florida House Committee has unanimously approved a measure that would allow the use of telehealth in certain aspects of cannabis treatment. Bill HB 387 would make it possible for doctors to use telehealth to renew their patients’ medical cannabis approvals. According to sponsor Rep Spencer Roach, the bill would treat medical cannabis like any other pharmaceutical. Venice-based physician Dr. Barry Gordon told the House Health Care Regulation Subcommittee before the vote that leveraging telehealth to renew medical cannabis certifications would benefit the most vulnerable Floridians. As dozens of states have legalized marijuana for medical use, millions of people across…

MondayMar 20, 2023 4:20 am

420 with CNW — Bill Targeting Illicit Marijuana Grows Designed to Safeguard Users from Pesticides

A bipartisan pair of congressional lawmakers has refiled a draft law meant to address the growing problem of illicit cannabis plantations on federal land. The lawmakers framed the legislation as a much-needed tool for the government to rein in illegal cannabis grows that are polluting the environment and risking marijuana consumers’ health. Although dozens of states have launched medical and recreational cannabis markets, America’s illicit cannabis market is still thriving. Licensed sellers struggle to compete with the illicit market as high taxes, and rigid rules have made legal cannabis several times more expensive than black-market marijuana. As a result, the…

FridayMar 17, 2023 4:20 pm

420 with CNW — Congressional Lawmakers Want Cannabis Scheduling Review More Transparent

On March 9, 2023, a group of nonpartisan Congress legislators penned a letter to senior Biden administration figures asking for transparency on the president's ongoing review of marijuana's legalization. A draft of the letter was recently distributed by Rep. Earl Blumenauer (D-OR) among Congress for signatures before being sent to Xavier Becerra, secretary of Health and Human Services (HHS), and Merrick Garland, United States attorney general. According to the letter’s content, Biden's scheduling directive presents a chance to evaluate the causes and effects of federal law in an open-minded manner. It also states that cannabis scheduling was based on prejudice…

FridayMar 17, 2023 4:20 am

420 with CNW — Bipartisan Legislators File Bill Allowing Those with Drug Convictions Access to Hemp Industry

Bipartisan congressional legislators have filed a new measure to end the "discriminatory" federal rule that prevents people with prior felonies for drug offenses from owning or operating legal hemp businesses. The "Free to Grow Act," sponsored by Representatives Chellie Pingree (D-ME), David Trone (D-MD), Nancy Mace (R-SC) and Dave Joyce (R-OH), focuses only on the section of the 2018 Farm Bill that dealt with prior convictions and federal legalized hemp. Pingree stated that in spite of legalization, the industry's expansion is being hampered by bureaucracy, regulatory uncertainty and discriminatory policy. Congress is expected to approve a new farm bill version…

ThursdayMar 16, 2023 4:20 pm

420 with CNW — DOJ Appeals Federal Ruling on Gun Rights for Marijuana Users

The U.S. Department of Justice is appealing a recent ruling by Federal Judge Patrick Wyrick that deemed it unconstitutional to prevent people who use state-legal marijuana from using guns. The Justice Department revealed in a filing to the Western District of Oklahoma U.S. District Court that it would appeal the ruling at the U.S. Court of Appeals for the Tenth Circuit. The appeal announcement by the U.S. government comes just a month after Wyrick’s landmark ruling. Although the two-page filing doesn’t elaborate on the arguments behind the ban, U.S. Attorney Robert Troester and Assistant U.S. Attorney David McCray will flesh…

News and publishing service for cannabis related companies

Contact us: 303.498.7722